Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
Pan-Ngum, Wirichada
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach. [electronic resource] - Vaccine 01 2017 - 403-409 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2016.10.073 doi
Child, Preschool
Disease Transmission, Infectious--prevention & control
Female
Humans
Infant
Infant, Newborn
Kenya--epidemiology
Male
Models, Theoretical
Respiratory Syncytial Virus Infections--epidemiology
Respiratory Syncytial Virus Vaccines--administration & dosage
Respiratory Syncytial Viruses--immunology
Time Factors
Treatment Outcome
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach. [electronic resource] - Vaccine 01 2017 - 403-409 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2016.10.073 doi
Child, Preschool
Disease Transmission, Infectious--prevention & control
Female
Humans
Infant
Infant, Newborn
Kenya--epidemiology
Male
Models, Theoretical
Respiratory Syncytial Virus Infections--epidemiology
Respiratory Syncytial Virus Vaccines--administration & dosage
Respiratory Syncytial Viruses--immunology
Time Factors
Treatment Outcome